It has been 70 years since the discovery of the DNA double helix and 20 years since the completion of the Human Genome Project - both seminal moments in the field of genomics.
Recently attending the Veeva R&D and Quality Summit in Madrid, pharmaphorum web editor Nicole Raleigh sat down with Veeva’s president of Europe, Chris Moore.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
